what are all the semaglutide brands – SpringCare Clinic Buy Semaglutide (Rybelsus Brand) |

Q2 2025 Snapshot Eli Lilly and Company dominates the US 57 % GLP-1 share, led by Mounjaro (tirzepatide) HCP & Zepbound (tirzepatide) HCP Novo Nordisk rules Europe 63 % value share, powered by Wegovy(semaglutide) injection 2.4 mg HCP & Ozempic APAC & Emerging Markets are the next frontier (+1113 % YoY) Together, they crossed $24 Billion in H1 2025 GLP-1 revenue proving the real blockbuster of this decade isnt oncology or immunology Its metabolic health

They figured that out

The clinical trials showing an average 14.9% weight loss over 68 weeks used Wegovys 2.4 mg dose, so theoretically Wegovy might produce slightly better results

What I find particularly impressive, speaking as a fellow manufacturer, is the scale of the companys scientific workforce

Worldwide esophageal cancer collaboration

Higher growth hormone supports fat loss and lean muscle